Cargando…
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Glioblastoma (GBM) remains the most lethal malignant tumours. Gboxin, an oxidative phosphorylation inhibitor, specifically restrains GBM growth by inhibiting the activity of F(0)F(1) ATPase complex V. However, its anti-GBM effect is seriously limited by poor blood circulation, the blood brain barrie...
Autores principales: | Zou, Yan, Sun, Yajing, Wang, Yibin, Zhang, Dongya, Yang, Huiqing, Wang, Xin, Zheng, Meng, Shi, Bingyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382535/ https://www.ncbi.nlm.nih.gov/pubmed/37507371 http://dx.doi.org/10.1038/s41467-023-40280-3 |
Ejemplares similares
-
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
por: Shi, Yufeng, et al.
Publicado: (2019) -
Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
por: Zhou, Yutong, et al.
Publicado: (2020) -
Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy
por: Liu, Yanjie, et al.
Publicado: (2022) -
Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy
por: Sun, Yajing, et al.
Publicado: (2021) -
Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma
por: Zhang, Dongya, et al.
Publicado: (2022)